ENBIO Co., Ltd. (KOSDAQ:352940)
South Korea · Delayed Price · Currency is KRW 2,135.00
0.00 (0.00%)
At close: Feb 6, 2026
ENBIO Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -351.79 | 645.61 | -6,300 | -3,445 | 5,245 | -4,449 |
Depreciation & Amortization | 1,779 | 1,779 | 2,607 | 2,239 | 2,289 | 2,177 |
Loss (Gain) From Sale of Assets | -419.04 | -419.04 | -20 | - | -132.41 | -14.95 |
Asset Writedown & Restructuring Costs | 292.48 | 292.48 | 509.94 | 244.5 | 390.6 | 220.4 |
Loss (Gain) From Sale of Investments | -270.53 | -270.53 | 755.96 | 6.12 | 2.67 | - |
Provision & Write-off of Bad Debts | 17.64 | 17.64 | 147.25 | 23.76 | -94.5 | 1,333 |
Other Operating Activities | 476.37 | 7.12 | 1,117 | -1,977 | -5,252 | 6,951 |
Change in Accounts Receivable | 1,143 | 1,143 | 10,901 | -1,612 | 1,377 | -617.42 |
Change in Inventory | 2,442 | 2,442 | 1,473 | -5,015 | -4,610 | -592.81 |
Change in Accounts Payable | -308.1 | -308.1 | 250.26 | 501.74 | -979.75 | -3.28 |
Change in Other Net Operating Assets | -427.47 | -427.47 | -520.14 | 533.78 | -524.11 | -1,204 |
Operating Cash Flow | 4,373 | 4,901 | 10,921 | -8,499 | -2,289 | 3,799 |
Operating Cash Flow Growth | -58.58% | -55.12% | - | - | - | - |
Capital Expenditures | -4,395 | -8,665 | -154.67 | -179.67 | -2,915 | -311.76 |
Sale of Property, Plant & Equipment | -38.35 | 780 | 20 | - | 184.1 | 139.95 |
Sale (Purchase) of Intangibles | -133.8 | -149.32 | -901.43 | -907.9 | -740.54 | -782.63 |
Investment in Securities | 1,122 | - | 2,185 | -1,467 | -2,027 | -6.88 |
Other Investing Activities | -18.8 | 34.64 | -106.72 | -98.11 | -37.21 | -202.87 |
Investing Cash Flow | -3,464 | -8,000 | 1,043 | -2,653 | -5,537 | -1,164 |
Short-Term Debt Issued | - | 21,605 | 17,695 | 10,543 | 14,969 | - |
Long-Term Debt Issued | - | 4,000 | - | - | 21,400 | 630 |
Total Debt Issued | 27,962 | 25,605 | 17,695 | 10,543 | 36,369 | 630 |
Short-Term Debt Repaid | - | -23,740 | -17,277 | -9,743 | -13,145 | -2,734 |
Long-Term Debt Repaid | - | -724.46 | -20,749 | -648.02 | -4,277 | -1,335 |
Total Debt Repaid | -29,253 | -24,464 | -38,026 | -10,391 | -17,423 | -4,069 |
Net Debt Issued (Repaid) | -1,291 | 1,140 | -20,331 | 152.07 | 18,947 | -3,439 |
Issuance of Common Stock | - | - | - | - | 2,350 | 9,575 |
Other Financing Activities | -0 | - | -40 | -58 | 53 | 0 |
Financing Cash Flow | -1,291 | 1,140 | -20,371 | 94.07 | 21,350 | 6,136 |
Foreign Exchange Rate Adjustments | 0.42 | 0.23 | 9.5 | -1.44 | 0.09 | -1.83 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - |
Net Cash Flow | -381.99 | -1,958 | -8,398 | -11,059 | 13,524 | 8,768 |
Free Cash Flow | -21.91 | -3,763 | 10,766 | -8,679 | -5,205 | 3,487 |
Free Cash Flow Margin | -0.07% | -10.55% | 31.64% | -25.35% | -15.55% | 10.09% |
Free Cash Flow Per Share | -2.02 | -346.30 | 991.10 | -798.65 | -462.61 | 421.64 |
Cash Interest Paid | 1,071 | 1,041 | 641.19 | 367.03 | 284.9 | 552.15 |
Cash Income Tax Paid | 0.13 | -46.75 | 13.65 | 364.31 | 564.01 | 540.6 |
Levered Free Cash Flow | 653.95 | -3,295 | 2,726 | -11,519 | -6,597 | 7,903 |
Unlevered Free Cash Flow | 1,061 | -2,887 | 4,256 | -10,203 | -6,085 | 8,403 |
Change in Working Capital | 2,849 | 2,849 | 12,104 | -5,591 | -4,737 | -2,418 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.